NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results